Interested in in vitro assays to assess the risk of cytokine storms? Or in vitro evaluation of compound effects on leukemic progenitors vs normal progenitors? So are we!
ReachBio Research Labs presented two posters at the recent Society of Toxicology conference in Phoenix, AZ. One on comparing assays for cytokine storm risk assessment of biologics and the other on an in vitro assay for evaluating the effects of compounds on leukemic progenitors vs their normal bone marrow counterparts. Please feel free to download a copy of each.
Click on the title to download a copy of the poster.
"Comparison of three methods for the evaluation of cytokine storm risk in early and clinical stage biopharmaceutical development"
Presenting author: Gary dos Santos
Abstract #270, Poster board #455
Monday, March 24
9:30am – 12:30pm
"An Ex vivo platform to evaluate the differential effects of potential therapies on leukemia progenitors (CFU-L) vs normal bone marrow progenitors (CFU-GM)"
Presenting author: Emer Clarke (CSO)
Abstract #1920, Poster board #321
Wednesday, March 26
1:00pm – 4:30pm